| An Update on New Drugs from
the May 2002 Meeting of the American Society of Clinical Oncology
By Amy D'Orazio, PhD, Kathy LaTour. and
Kavita Maung, PhD
Doctors Doctors Everywhere
More than 20000 people gathered in Orlando Florida
the weekend of May 16 to talk about cancer at the 38th annual meeting
of the American Society of Clinical Oncology (ASCO). From its inception
in the mid 60s when fewer than 200 gathered for a few
meetings about advances in cancer ASCO has grown to this years
934 presentations made by 2473 faculty.
ASCO is not just a story of size but an evolution of
thinking In the opening ceremony ASCO President
Larry Norton MD Memorial Sloan-Kettering Cancer Center
reiterated one of the goals of ASCO: common concern for the patient
with cancer basic research clinical investigation
and better utilization current means.
Dr. Norton said. He talked about the introduction of targeted therapies
interventional cancer prevention health services research
stem cell transplantation hereditary susceptibility
and molecular oncology.
Much of the conference looked at new targeted therapies like those
covered in CURE. Indeed Andrew von Eschenbach MD
the newly appointed director of the National Cancer Institute and
a cancer survivor spoke of the evolution of cancer care in
the 21st century as moving from weapons of destruction to
interventions for control and prevention. Dr. von Eschenbach
said that although the seek- and-destroy paradigm has helped to
increase five-year survival rates overall survival rates are
still at unacceptable levels adding that we are looking
at attacking cancer with a combination of integrated therapies.
The four-day event was filled from morning to night with presentations
on the latest success in clinical trials for new drugs and new drug
combinations as well as new research directions and a myriad of
other clinical and research questions.
Education sessions focused on issues of importance to physicians
and patientsincluding complementary and alternative healing
cancer genetics pain management doctor-patient communication
challenges in dealing with an older population and new approaches
for a wide range of cancers.
To get an overview of these presentations go to www.plwc.org
(People living with cancer) ASCOs newly launched website
which gives you access to all the findings at ASCO. There are also
sections of the People Living With Cancer website dedicated to specific
types of cancer clinical trialsv symptom management
caregiving cancer news family and friends ASCO
resources and more. ASCO members have approved the medical
content on the website so readers can feel confident that
the information is medically correct and up-to-date. Watch for announcements
about the release of the second edition of ASCOs Cancer Handbook
new ASCO Patient Guides and exciting features coming soon
to the website.In his concluding remarks Dr. Norton saidEvery
one of us could be a cancer patient every one of us could
be a cancer healer and it is finding and perfecting that healer
in each one of us that is the value that makes ASCO work.
|